当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析 - 现金流量表

泰格医药

(300347)

  

流通市值:330.67亿  总市值:502.84亿
流通股本:5.66亿   总股本:8.61亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,111,313,981.512,034,062,055.587,252,500,492.855,317,979,333
  收到的税费返还17,056,864.282,677,768.2318,708,343.1314,560,502.32
  收到其他与经营活动有关的现金54,184,102.1353,706,326.07100,557,127.0681,749,437.45
  经营活动现金流入小计4,182,554,947.922,090,446,149.887,371,765,963.045,414,289,272.77
  购买商品、接受劳务支付的现金1,321,495,382.25654,921,629.082,385,493,371.311,592,666,205.03
  支付给职工以及为职工支付的现金1,828,304,817.5811,053,535.183,201,531,424.162,363,815,844.1
  支付的各项税费338,391,468.73111,725,928.93391,733,866.32320,605,174.81
  支付其他与经营活动有关的现金268,580,944.15195,041,280.33274,922,530.71397,644,419.26
  经营活动现金流出小计3,756,772,612.631,772,742,373.526,253,681,192.54,674,731,643.2
  经营活动产生的现金流量净额425,782,335.29317,703,776.361,118,084,770.54739,557,629.57
二、投资活动产生的现金流量:
  收回投资收到的现金859,983,284.4353,734,657.822,190,670,618.941,777,634,145.31
  取得投资收益收到的现金250,455,802.79118,504,208.43639,151,660.33165,736,772.1
  处置固定资产、无形资产和其他长期资产收回的现金净额467,631.24275,166.525,933,203.192,139,573.13
  收到的其他与投资活动有关的现金--67,746,984.3117,128,630.27
  投资活动现金流入小计1,110,906,718.43472,514,032.772,903,502,466.771,962,639,120.81
  购建固定资产、无形资产和其他长期资产支付的现金106,102,426.950,430,337.37214,369,102.48173,581,867.91
  投资支付的现金949,339,788.82338,564,515.281,915,690,187.331,138,161,366.31
  取得子公司及其他营业单位支付的现金400,000400,000164,946,844.98115,646,821.75
  支付其他与投资活动有关的现金6,252,217.728,882,924.28116,939,779.7541,542,266.82
  投资活动现金流出小计1,062,094,433.42418,277,776.932,411,945,914.541,468,932,322.79
  投资活动产生的现金流量净额48,812,285.0154,236,255.84491,556,552.23493,706,798.02
三、筹资活动产生的现金流量:
  吸收投资收到的现金166,913,467.37114,736,849.16223,654,000162,098,000
  其中:子公司吸收少数股东投资收到的现金166,913,467.37---
  取得借款收到的现金1,169,980,559.5234,127,7001,137,864,305.841,044,986,871.59
  收到其他与筹资活动有关的现金2,140,799.6-60,576,00061,200,000
  筹资活动现金流入小计1,339,034,826.47348,864,549.161,422,094,305.841,268,284,871.59
  偿还债务支付的现金408,214,609.43158,269,636.32,373,696,294.12,170,230,969.65
  分配股利、利润或偿付利息支付的现金69,717,365.8714,967,990.38343,659,038.48341,108,089.3
  其中:子公司支付给少数股东的股利、利润30,568,995.29---
  支付其他与筹资活动有关的现金991,682,109.58168,051,754.39631,424,182.78441,734,176.59
  筹资活动现金流出小计1,469,614,084.88341,289,381.073,348,779,515.362,953,073,235.54
  筹资活动产生的现金流量净额-130,579,258.417,575,168.09-1,926,685,209.52-1,684,788,363.95
四、汇率变动对现金及现金等价物的影响-23,544,743.26-14,454,893.77-8,841,588.412,935,487.08
五、现金及现金等价物净增加额320,470,618.63365,060,306.52-325,885,475.16-448,588,449.28
  加:期初现金及现金等价物余额1,722,608,377.681,722,608,377.682,048,493,852.842,048,493,852.84
  期末现金及现金等价物余额2,043,078,996.312,087,668,684.21,722,608,377.681,599,905,403.56
补充资料:
  净利润-185,471,319.77-805,056,174.52-
  资产减值准备877,227.81-37,043,406.56-
  固定资产和投资性房地产折旧73,408,629.08-133,420,590.25-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧73,408,629.08-133,420,590.25-
  无形资产摊销37,963,678.18-78,338,419.78-
  长期待摊费用摊销22,070,533.96-42,809,046.7-
  处置固定资产、无形资产和其他长期资产的损失18,083,068.74--3,650,548.27-
  固定资产报废损失--1,089,100.07-
  公允价值变动损失443,323,794.17--42,256,274.39-
  财务费用42,390,160.85-107,509,287.27-
  投资损失2,431,886.75--433,815,899.7-
  递延所得税-5,614,772.27--48,218,232.93-
  其中:递延所得税资产减少-3,939,037.85--18,142,797.11-
    递延所得税负债增加-1,675,734.42--30,075,435.82-
  存货的减少-25,023,970.59--9,516,013.06-
  经营性应收项目的减少-107,962,153.27--199,801,117.54-
  经营性应付项目的增加56,834,672.08-511,487,999.77-
  其他4,742,685.45-23,680,964.04-
  现金的期末余额2,043,078,996.31-1,722,608,377.68-
  减:现金的期初余额1,722,608,377.68-2,048,493,852.84-
  现金及现金等价物的净增加额320,470,618.63--325,885,475.16-
公告日期2026-08-292026-04-292026-03-312025-10-29
审计意见(境内)标准无保留意见
TOP↑